Feasibility and Outcomes of Repeat Epicardial Access in Arrhythmogenic Right Ventricular Cardiomyopathy.

Key Points

• To assess the feasibility and outcomes of repeat epicardial access for patients with arrhythmogenic right ventricular cardiomyopathy.
• Conducted as a randomized trial
• Participants included those diagnosed with arrhythmogenic right ventricular cardiomyopathy
• Evaluated outcomes of repeat epicardial access interventions
• Achieved successful repeat epicardial access in 85% of cases
• Significantly improved arrhythmia control with a 30% reduction in adverse events
• P=0.005 indicating high efficacy of the intervention